NCT04336631

DCP3 Based Multi-component Intervention for Hypertension Management and Control

Completed NA Last updated 8 April 2020

What this trial tests

NA trial testing Intervention on DCP3 based strategies for Hypertension Management and Control in Hypertension in 500 participants. Completed in 30 March 2020.

Timeline

1 November 2019

Primary endpoint
1 January 2020

30 March 2020

Quick facts

Lead sponsor	Health Services Academy, Islamabad, Pakistan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	screening
Enrollment	500
Start date	1 November 2019
Primary completion	1 January 2020
Estimated completion	30 March 2020
Sites	1 location across Pakistan

Drugs / interventions tested

• Intervention on DCP3 based strategies for Hypertension Management and Control

Conditions studied

• Hypertension — all drugs for Hypertension →
• Hypertensive Patients — all drugs for Hypertensive Patients →

Sponsor

Health Services Academy, Islamabad, Pakistan

Who can join

Eligibility, any sex, with Hypertension or Hypertensive Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to enable delivery of a multi-component intervention comprising of strategies based on Disease Control Priorities 3rd edition for management of hypertension among hypertensive patients. The secondary objective is to test the feasibility, acceptability and adaptability of a multi-component intervention delivered at a tertiary level health-care facility in the cultural context of Pakistan. A formative research study was conducted before so as to develop and test the intervention in a tertiary care hospital setting. The investigators employed qualitative research methods to explore the feasibility, applicability, and acceptance of DCP3 based intervention comprising of strategies for hypertension management. Focus group discussions and in-depth interviews with selected study participants were conducted at Armed Forces Institute of Cardiology (AFIC/NIHD), Rawalpindi for which a prior written and verbal consent was obtained from all research participants. The study adhered to the ethical principles of involving human subjects in the research. All information provided by the participants was recorded and was kept strictly confidential.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. A Randomized Controlled Trial of Blood Pressure Reduction Based on Disease Control Priorities 3 in Pakistan to Manage and Control Hypertension.
   Khan SA, Hafeez A, Zaka A, Khan SA, et al · · 2023 · cited 1× · PMID 37493898 · DOI 10.1007/s40292-023-00589-y
2. A Randomized Controlled Trial Study on Hypertension Reduction Based on Disease Control Priorities to Manage High Blood Pressure
   Khan SA, Khan SA, Hafeez A, Zaka A. · · 2021 · DOI 10.21203/rs.3.rs-704550/v1